Curewell Capital

Description

Curewell Capital is a growth-oriented investment firm focused on building industry-leading healthcare companies. Drawing upon decades of investment and operating experience in healthcare services, medical devices, life sciences and pharmaceutical services, Curewell Capital partners with owners and management teams leading extraordinary companies that improve patient outcomes, reduce cost and foster innovation. Curewell Capital’s proprietary GRO™ framework is tailored to each company to drive long-term value through growth and operational excellence. The firm is based in Los Angeles, California.

Curewell Capital is a Los Angeles-based private equity firm with a $535 million debut fund dedicated to acquiring and building middle-market healthcare companies across healthcare services, pharmaceutical services, medical devices, and healthcare technology. They have no current dental holdings but carry a clear platform-acquisition mandate in healthcare services that makes them a plausible dental or multi-site healthcare rollup buyer.

Curewell Capital is a private equity firm that closed a $535 million inaugural fund focused on acquiring middle-market healthcare companies across healthcare services, pharmaceutical services, medical devices, and healthcare technology — a clear mandate to acquire healthcare-services platforms, making them a credible dental/healthcare-services platform buyer.

enriched 2026-05-05

Financials